Background—The long-term safety of drug-eluting stents (DES) for acute myocardial
infarction (AMI) remains uncertain. Using autopsy data, we evaluated the pathological …

Objectives: The study interrogated an autopsy registry to investigate the histopathologic
features of early stent thrombosis (ST) in patients presenting with acute coronary syndrome …

Background Studies comparing percutaneous coronary intervention (PCI) with drug-eluting
and bare-metal coronary stents in acute myocardial infarction have been limited in size and …

Objectives: This study examined human drug-eluting stents (DES) to determine the long-
term effects of these stents on coronary arterial healing and identified mechanisms …

Objectives: This study sought to investigate whether self-expanding stents are more effective
than balloon-expandable stents for reducing stent malapposition at 3 days after implantation …

BACKGROUND: Recent trials have shown the effects of drug-eluting stents (DES) in
treatment of acute myocardial infarction (AMI), but data on the clinical outcome are still …

Objectives: We sought to identify patients with ST-segment elevation myocardial infarction
most likely to benefit from drug-eluting stents (DES), and to evaluate the impact of routine …

Objectives: The aim of this study was to compare the frequency of incomplete stent
apposition (ISA) and struts not covered by tissue at long-term follow-up (as assessed by …

Objectives: The purpose of this study was to compare long-term clinical outcomes after
implantation of drug-eluting stents (DES) and bare-metal stents (BMS) in patients with ST …

Among 138 patients treated with coronary angioplasty during acute myocardial infarction
(AMI), 35 (25%) had stent implantation. Mean age was 56 years and 83% were men. Mean …